You're reading: New York Times: A FDA panel recommends the Pfizer-BioNTech vaccine for young children

New York Times: A FDA panel recommends the Pfizer-BioNTech vaccine for young children

Published Oct. 27, 2021. Updated Oct. 27 at 3:00 am

Children wearing face masks play on their scooters during the coronavirus pandemic on April 25, 2020 in New York City.

Photo by AFP

An expert committee advising the Food and Drug Administration on Tuesday recommended that regulators authorize Pfizer-BioNTech’s coronavirus vaccine for 5- to 11-year-olds, bringing about 28 million children a major step closer to becoming eligible for shots.